by Rachel Montague | Jul 25, 2022 | Industry insights
Written by Beth Hancock, Senior Consultant Health Economist Pharmaceutical companies often develop global cost-effectiveness and budget impact models, with the aim of adapting them for specific countries. In principle, this is an efficient and streamlined process, but...
by Rachel Montague | Jun 17, 2022 | Industry insights, Source news, Uncategorised
Written by Alec Miners, Head of Health Economics The National Institute for Health and Care Excellence’s (NICE’s) new processes and methods guide includes several important changes to the way submitted economic evaluations should be conducted (1). While the headline...
by Rachel Montague | Jun 7, 2022 | Industry insights
Written by Pip White, Principal Medical Writer The IMF The Innovative Medicines Fund (IMF) launched this month (June 2022) to support faster access to non-cancer drugs. This process involves National Health Service (NHS) England and the National Institute for Health...
by Rachel Montague | May 26, 2022 | Industry insights
Written by Chris Hellmund, Senior Medical Writer Antimicrobial resistance is a major threat to global health that threatens to reverse the progress of modern medicine. More infections are becoming harder to treat, and without coordinated efforts we face a future in...
by Rachel Montague | May 18, 2022 | Industry insights
Written by Abby Paine, Statistician It’s National Numeracy Day, which is run by National Numeracy, a charity that aims to enable everyone across the UK to be confident and competent in using numbers and data. This is such an important issue; you may not realise it,...
by Rachel Montague | May 17, 2022 | Industry insights
Written by Isobel Munro, Associate Systematic Review Analyst The purpose of conducting a systematic literature review (SLR) is to identify a complete and unbiased set of studies relevant to the proposed research question. However, it is not only studies that have been...
